GlassScriptPhysician profile
Anthony James Scillia
NPI 1518151547
$56,429.25
in general payments reported to CMS, 2019-2025
27 companies · $11K in 2025
The $11K reported for 2025 was more than what 88% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,535 · 2020: $6,464 · 2021: $732 · 2022: $16K · 2023: $3,366 · 2024: $11K · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $19K · Food and Beverage: $3,182 · Travel and Lodging: $3,068.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $18,926.25 |
| Food and Beverage | $3,182.30 |
| Travel and Lodging | $3,067.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $41,130.12 | 2019-2025 | Na, Rigidloop, N/A |
| Depuy Synthes Products, INC. | $6,712.25 | 2020-2025 | |
| Depuy Synthes Sales INC. | $2,084.91 | 2019-2025 | Dynatape, Dynacord, Vapr |
| Arthrex, INC. | $1,185.56 | 2022-2025 | |
| Seapearl East, INC | $1,174.02 | 2022-2025 | |
| Stryker Corporation | $1,075.47 | 2021-2025 | Tritanium, Nanotack Flex, N/A |
| Globus Medical, INC. | $821.74 | 2020-2022 | |
| Smith+Nephew, INC. | $328.40 | 2024-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Miach Orthopaedics, INC. | $311.24 | 2023-2024 | |
| Pacira Therapeutics, INC. | $306.62 | 2019-2021 | |
| Linvatec Corporation | $301.72 | 2020-2022 | |
| Davol INC. | $246.62 | 2021 | |
| Zimmer Biomet Holdings, INC. | $186.46 | 2021-2025 | Tapestry |
| Medtronic, INC. | $155.85 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $114.66 | 2022-2025 | Exparel |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $56.73 | 2019-2022 | |
| Conmed Corporation | $46.80 | 2022 | |
| Horizon Therapeutics Plc | $39.62 | 2020-2022 | |
| Bioventus LLC | $31.46 | 2022 | |
| Arthrosurface Incorporated | $18.12 | 2019 | |
| Avanos Medical | $17.94 | 2022 | |
| Sunovion Pharmaceuticals INC. | $16.87 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $15.00 | 2022 | |
| Zyla Life Sciences, INC. | $14.92 | 2020 | |
| Ethicon US, LLC | $14.79 | 2024 | Dermabond Prineo, Stratafix |
| Vertical Pharmaceuticals, LLC | $13.73 | 2019 | |
| Heraeus Medical, LLC. | $7.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Scillia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.